Cardiac Injury Due to Anthracycline in Paediatric Oncological Patients
NCT06898320 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 22
Last updated 2025-05-09
Summary
The study investigates the role of echocardiography and of serum biomarkers (NT-proBNP, cardiac Troponin-I) in predicting cardiac injury in a cohort of paediatric oncological patients treated with Anthracycline chemotherapy.
Conditions
- Heart Injuries
- Anthracycline
Sponsors & Collaborators
-
IRCCS Burlo Garofolo
lead OTHER
Principal Investigators
-
Thomas Caiffa, MD · IRCCS Burlo Garofolo
Eligibility
- Min Age
- 0 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-21
- Primary Completion
- 2033-07-21
- Completion
- 2033-07-21
Countries
- Italy
Study Locations
More Related Trials
-
Prediction of Delayed Toxic Cardiomyopathy in Children
NCT05781672 ·Status: TERMINATED ·Phase: NA
-
Early Detection of Cardiomyopathy by Speckle Echo, High Sensitive Troponin and Cardiac Ryanodine Receptors
NCT03381014 ·Status: UNKNOWN
-
Early Detection of Cardiac Toxicity in Childhood Cancer Survivors
NCT03038997 ·Status: TERMINATED
-
A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging
NCT02993198 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Optimising Screening for the Cardiotoxic Effects of Cancer Therapy
NCT06817044 ·Status: COMPLETED
-
Cardiac Dysfunction in Childhood Cancer Survivors
NCT03790943 ·Status: RECRUITING
-
TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography
NCT06310330 ·Status: RECRUITING ·Phase: NA
-
Subclinical Cardio-toxicities Evaluation With Strain Rate Echocardiography After Chemotherapy and/or Mediastinal Radiotherapy in Patient With Lymphoma
NCT03480087 ·Status: COMPLETED
-
Cardiac Impairments Following Pediatric Cardiotoxic Anti-cancer Treatment
NCT05261256 ·Status: ENROLLING_BY_INVITATION
-
Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping
NCT06048458 ·Status: UNKNOWN
-
Early Detection of Imaging-derived Subclinical Cardiac Injuries
NCT03575650 ·Status: RECRUITING
-
NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity
NCT06340516 ·Status: RECRUITING ·Phase: NA
-
Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients
NCT02062983 ·Status: SUSPENDED
-
Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors
NCT02485626 ·Status: UNKNOWN
-
Study of Myocardial Function by Speckle Tracking After Cancer Treatment With Anthracyclines in Childhood
NCT02893787 ·Status: COMPLETED
-
Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer Patients
NCT04790266 ·Status: COMPLETED
-
Cardiotoxicity of Cancer Therapy (CCT)
NCT01173341 ·Status: ENROLLING_BY_INVITATION
-
Monitoring Radiation Induced Cardiac Damage by Blood Markers
NCT02481778 ·Status: COMPLETED
-
New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.
NCT05992337 ·Status: UNKNOWN
-
Quantification and Description of the Increase in Serum Troponin Following Acute Coronary Syndrome
NCT01698021 ·Status: UNKNOWN
-
Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma
NCT07041827 ·Status: COMPLETED
-
Early Detection of Cardiac Damage With CMR in Women With Breast Cancer
NCT04046315 ·Status: UNKNOWN
-
Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications
NCT06321692 ·Status: RECRUITING ·Phase: NA
-
Troponin in Acute Chest Pain to Risk Stratify and Guide EffecTive Use of Computed Tomography Coronary Angiography
NCT03952351 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Early Detection of Broken Hearts in Cancer Patients
NCT02086695 ·Status: COMPLETED